title: Advocacy groups are crucial players in developing new neurotherapeutics.
authors.affiliation: Beryl Lieff Benderly, Inc., Washington, DC 20015, USA.
authors.forename: Beryl Lieff
authors.initials: BL
authors.lastname: Benderly
mesh_terms: D003254:Consumer Advocacy; D004345:Drug Industry / Q000639:trends; D006801:Humans; D009422:Nervous System Diseases / Q000628:therapy*; D014481:United States; D014486:United States Food and Drug Administration